Skip to main navigation

Skip to main content

About
Our Story Our People
Science
Pipeline Izokibep Lonigutamab SLRN-517 Presentations & Publications
Community
Patients Partnerships
Investors & Media
Overview Press Releases Events & Presentations Financials & Filings Corporate Governance Email Alerts Investor Resources Media Resources
Careers
Stories

Contact Us

Event Details

Top-line Results from Phase 2b/3 Trial of Izokibep in Psoriatic Arthritis

Mar 11, 2024

Email Alerts
RSS Feeds
Contact Investor Relations
Contact Media Relations

Building an innovative biopharma company that invests in, develops and commercializes life-changing drug therapies.

Get company updates to your inbox

green arrow icon

Sitemap

About Science Community Investors & Media Careers Stories Contact Us

Headquarters

4149 Liberty Canyon Rd
Agoura Hills, CA 91301

South San Francisco Office

701 Gateway Blvd, Suite 300
South San Francisco, CA 94080

Social Media

^©2024 ACELYRIN, INC. All Rights Reserved. | ACELYRIN and the ACELYRIN logo are trademarks of ACELYRIN, INC.

Privacy Policy |
Terms |
|

Facebook
Twitter
LinkedIn
Email Page